SHORT MINI-FUTURE - MERCK & CO. Stock

Certificat

DE000VM9RMH3

Delayed Deutsche Boerse AG 04:21:14 2024-05-10 EDT
1.96 EUR -2.97% Intraday chart for SHORT MINI-FUTURE - MERCK & CO.
Current month-1.94%
1 month-15.13%
Date Price Change Volume
24-05-10 1.96 -2.97% 0
24-05-09 2.02 -2.88% 0
24-05-08 2.08 -2.35% 0
24-05-07 2.13 -6.17% 0
24-05-06 2.27 +1.34% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 04:21 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9RMH
ISINDE000VM9RMH3
Date issued 2024-02-05
Strike 151.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.47
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.91
Lowest since issue 1.72
Spread 0.08
Spread %3.96%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2 USD
Average target price
141.6 USD
Spread / Average Target
+8.76%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW